SCHEMBL486093

SCHEMBL486093

CCNc1nc(-c2ccc(NC(=O)NCc3ccc(N)nc3)c(F)c2)ccc1C(=O)NC.CCNc1nc(-c2ccc(NC(=O)NCc3ccc(N)nc3)c(F)c2)ccc1C(=O)NCCN1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.39
MTOR P42345 5/20 0.39
KIT P10721 1/20 0.39
MAP4K4 O95819 2/20 0.38
MET P08581 2/20 0.38
PDPK1 O15530 2/20 0.37
IKBKB O14920 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EPHX2 P34913 1/20 0.36
MAPK1 P28482 1/20 0.36
NAMPT P43490 1/20 0.36
KCNH2 Q12809 2/20 0.35
CHRNA7 P36544 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485853 0.97 PIK3CA (0.41) PIK3CAMTORKITMAP4K4PDPK1
SCHEMBL485903 0.97 PIK3CA (0.41) PIK3CAMTORKITMAP4K4PDPK1
SCHEMBL485908 0.97 PIK3CA (0.41) PIK3CAMTORKITMAP4K4PDPK1
SCHEMBL485940 0.93 KCNH2 (0.41) PIK3CAMTORKITMETNAMPT
SCHEMBL486443 0.93 PIK3CA (0.41) PIK3CAMTORKIT
SCHEMBL485905 0.92 KCNH2 (0.42) PIK3CAMTORKITMETNAMPT
SCHEMBL486083 0.91 MTOR (0.40) PIK3CAMTORIKBKBMAPK1
SCHEMBL486010 0.91 MTOR (0.48) PIK3CAMTORKITIKBKBMAPK1
SCHEMBL486122 0.91 PIK3CA (0.39) PIK3CAMTORKITMAPK1
SCHEMBL485926 0.91 PIK3CA (0.39) PIK3CAMTORKITMAP4K4PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411368-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS SANOFI (FR) 2012-02-01 EP claimed
WO-2010109122-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS SANOFI-AVENTIS (FR) 2010-09-30 WO claimed